AHA Comments to CMS on the International Pricing Index Model for Medicare Part B Drugs

AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on the International Pricing Index model for Medicare Part B drugs.

Related Resources

Press Releases
Infographics
Public
Guides/Reports
Public
The American Hospital Association (AHA), the Federation of American Hospitals (FAH), and the American Society of Health-System Pharmacists (ASHP) released a…
Letter
Public
The AHA voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer tele
Special Bulletin
Member
Special Bulletin on CMS’s Nov. 26 proposed rule aimed at lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
Letter
The AHA urges the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and…